ISRCTN66066651已完成未知
The efficacy and safety of low-dose 5-aminolevulinic acid (ALA) thermosetting gel photodynamic therapy in the treatment of mild to moderate acne vulgaris
Cantabria Labs Difa Cooper0 个研究点目标入组 35 人开始时间: 2018年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
2019 results in https://pubmed.ncbi.nlm.nih.gov/29790262/ (added 23/11/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Mild to moderate acne vulgaris
排除标准
- •1. Severe acne
- •2. Skin phototype I
- •3. Positive history of skin tumor
- •4. Photodermatosis
研究者
相似试验
已完成
2 期
A study looking at how effective and safe a very low dose of dexamethasone is in helping ventilator-dependent preterm babies who are at high risk of bronchopulmonary dysplasia (a serious lung condition that affects infants) get off the ventilator more quickly and effectivelySpecialty: Children, Primary sub-specialty: NeonatalUKCRC code/ Disease: Reproductive Health and Childbirth/ Other disorders originating in the perinatal periodRespiratoryBronchopulmonary dysplasia (BPD)ISRCTN81191607niversity of Liverpool22
已完成
不适用
A study to investigate the effect of a sensitivity toothpaste in providing relief from tooth sensitivityTooth sensitivityOral HealthISRCTN16831120GlaxoSmithKline Consumer Healthcare240
已完成
不适用
ens replacement planning in patients with cataracts and corneal astigmatism using the iTrace programCataracts with corneal astigmatismEye DiseasesISRCTN94956424Shanxi Eye Hospital63
进行中（未招募）
不适用
Investigation of safety and efficacy of five doses of NNC 0113-0217 versus placebo and open-label liraglutide, as add on therapy, in subjects diagnosed with type 2 diabetes currently treated with metformin or controlled with diet and exerciseA 12 week multi-centre, multi national, double-blind, placebo-controlled, randomised, nine armed parallel group, dose finding trialtype 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-003956-12-HUovo Nordisk A/S517
进行中（未招募）
不适用
Investigation of safety and efficacy of five doses of NNC 0113-0217 versus placebo and open-label liraglutide, as add on therapy, in subjects diagnosed with type 2 diabetes currently treated with metformin or controlled with diet and exerciseA 12 week multi-centre, multi national, double-blind, placebo-controlled, randomised, nine armed parallel group, dose finding trial - NDType 2 Diabete MellitusMedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitusEUCTR2007-003956-12-ITOVO NORDISK517